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Alternative 39 and 59 splice site (ss) events constitute a significant part of all alternative splicing events. These events
were also found to be related to several aberrant splicing diseases. However, only few of the characteristics that
distinguish these events from alternative cassette exons are known currently. In this study, we compared the
characteristics of constitutive exons, alternative cassette exons, and alternative 39ss and 59ss exons. The results
revealed that alternative 39ss and 59ss exons are an intermediate state between constitutive and alternative cassette
exons, where the constitutive side resembles constitutive exons, and the alternative side resembles alternative
cassette exons. The results also show that alternative 39ss and 59ss exons exhibit low levels of symmetry (frame-
preserving), similar to constitutive exons, whereas the sequence between the two alternative splice sites shows high
symmetry levels, similar to alternative cassette exons. In addition, flanking intronic conservation analysis revealed that
exons whose alternative splice sites are at least nine nucleotides apart show a high conservation level, indicating
intronic participation in the regulation of their splicing, whereas exons whose alternative splice sites are fewer than
nine nucleotides apart show a low conservation level. Further examination of these exons, spanning seven vertebrate
species, suggests an evolutionary model in which the alternative state is a derivative of an ancestral constitutive exon,
where a mutation inside the exon or along the flanking intron resulted in the creation of a new splice site that
competes with the original one, leading to alternative splice site selection. This model was validated experimentally on
four exons, showing that they indeed originated from constitutive exons that acquired a new competing splice site
during evolution.
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Introduction
The human genome sequencing project has led to the
understanding that total gene number is not indicative of a
higher level of phenotypic complexity, as the number of
human genes is ;25,000, only slightly higher than the
nematode (;19,000 genes) and lower than rice (;40,000
genes) [1,2]. The mechanism that was proposed to resolve this
discrepancy is alternative splicing, in which several mRNA
isoforms are generated from a single gene through the
alternative selection of 39ss and/or 59ss, producing several
functional proteins [3,4]. There are ﬁve major forms of
alternative splicing: exon skipping (also known as cassette
exons), in which the exon as a whole either is included in the
mature mRNA transcript or is skipped. Exon skipping is the
most common alternative splicing event and accounts for
38% of conserved alternative splicing events between human
and mouse. Alternative 39ss exons (A3Es) and 59ss exons
(A5Es) account for ;18% and ;8% of the human–mouse
conserved events, respectively. These exons are ﬂanked on
one side by a constitutive splice site (ﬁxated) and on the other
side by two (or more) competing alternative splice sites,
resulting in an alternative region (extension) that either is
included in the transcript or is excluded. Intron retention
accounts for fewer than 3% of the human–mouse conserved
alternative splicing events, whereas the remaining ;33% are
different types of complex events [5,6]. Four splice signals are
essential for accurate splicing: 59 and 39 splice sites (59ss and
39ss), the polypyrimidine tract, and the branch site sequence
[7]. However, these signals solely can’t support proper splice
site selection and proper splicing. Cis-acting regulatory
elements called exonic splicing enhancers (ESEs) and exonic
splicing silencers (ESSs; ESEs þ ESSs are also termed ESRs)
were found to be involved in the regulation of the alternative
splicing process [8]. These elements have the major effect
when located in proximity to the alternative splice site [9–12].
Previous studies focused their research mainly on cassette
exons in the quest of identifying the regulatory mechanism
governing their splicing and the evolutionary background
that led to their creation [13,14]. In addition, other studies
have tried to examine the biological signiﬁcance and evolu-
tionary mechanism of intron-retained exons [15,16]. On the
other hand, A3Es and A5Es are relatively more poorly
characterized, even though they were found to be related to
several diseases caused by aberrant splicing generated by
mutations [17–19]. Thus, it is important to widen the
knowledge regarding their regulation, characteristics, and
evolutionary origin. Examination of A3Es and A5Es reveals
that their alternative region is highly diverse in terms of
length. However, ;50% of A3Es have alternative splice sites
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This was one of the reasons that led several studies to
examine a subset of A3Es and A5Es (containing a short
alternative region, 1–4 bp in length), in an attempt to learn
whether they are controlled by a highly complex regulatory
mechanism and serve as a ﬁne-tuning mechanism for protein
functionality [20–22] or are merely a meter of noise of the
splicing machinery [23]. A previous study showed that in
A3Es, an additional polypyrimidine tract (PPT) between the
two 39ss appears only when the distance between them is
more than 8 bp, whereas in A5Es, the GT dinucleotide located
4 bp downstream of the authentic GT in the 59ss sequence
(GTNNGT) can serve as a competing 59ss [24]. Other studies
have aimed to develop tools that will enable us to identify new
A3Es and A5Es based on different criteria [25,26]. However,
the evolutionary mechanism that led to their creation is
largely unknown.
Comparative genomics has been used as a powerful tool for
the identiﬁcation of functional biological features. The
guideline directing this approach is that a high conservation
level implies an essential biological function—structural or
regulatory [27]. Human–mouse comparison is the most
commonly used in research, because it is estimated that the
two species diverged 75–130 million years ago and, hence, had
enough time to accumulate mutations on the one hand while
still maintaining high levels of homology on the other. In
addition, nearly all human genes (99%) have a mouse
ortholog with a high (88%) protein coding sequence
resemblance [28]. Moreover, their genomes have been ex-
plored widely and their transcriptome covered by millions of
EST sequences, making it easier to perform large-scale
analyses.
It has been previously shown that constitutive and
alternative cassette exons differ from each other in several
features, such as: splice site strength, exon length, conserva-
tion level between human and mouse (exon identity),
divisibility-by-3 (symmetry), and KA/KS ratio test [6,14,29].
These discriminating features were also used to explore the
regulatory mechanism that is required to ensure the proper
splicing of these exons.
A3Es and A5Es can produce (at least) two splice transcripts:
one contains the extension, and the other excludes it. These
transcripts can be formed in different ratios, i.e., one can be
more abundant (major form) compared with the other (minor
form). Thus, the more common form of each exon can allude
to its evolutionary background. Thus, we examined each of
the aforementioned characteristics in A3Es and A5Es,
subdivided into two subgroups according to the common
form, and compared them with constitutive and alternative
cassette exons to understand the overall regulatory mecha-
nism that directs the proper selection of one alternative
splice site over the other. Our analysis was based on a uniﬁed
dataset of human–mouse orthologous exons comprising
constitutive exons, alternative cassette exons, A3Es, and
A5Es [6,30,31]. The analysis was expanded further to multiple
species alignment to acquire knowledge on the evolutionary
background of A3Es and A5Es from both subgroups. Our
results suggest an evolutionary model for the creation of new
A3Es and A5Es. According to this model, A3Es and A5Es
originated from constitutive exons that acquired a new
functional splice site as a result of a mutation in the exon
or along the intron. This splice site started to compete with
the authentic splice site, leading to alternative splice site
selection. We provide computational and experimental
evidence supporting this hypothesis.
Results
Characterization of Alternative 39 and 59 Exons
To identify unique characteristics of A3Es and A5Es, we
examined several features that can differentiate these exons.
We compiled four datasets of human–mouse orthologous
exons, including their ﬂanking introns: 45,553 constitutively
spliced exons, 757 alternative cassette exons, 530 A3Es, and
232 A5Es (see Materials and Methods). Each of the A3Es and
A5Es was represented by both ‘‘short’’ form (without the
alternative extension) and ‘‘full’’ form (with the alternative
extension).
We ﬁrst extracted the 39ss and 59ss of all the exons in the
datasets and examined their strength (Figure 1). We found
that while alternative cassette exons were shown to have
relatively weaker splice sites in comparison with constitutive
exons [32–35], A3Es and A5Es present a strong splice site in
the ﬁxated exon’s side (i.e., 59 in A3Es and 39 in A5Es),
resembling constitutive exons and statistically differing from
alternative cassette exons (Mann-Whitney, p¼4.39E-05 and p
¼8.67E-05 for A3Es and A5Es, respectively), and a weak splice
site in the alternative exon’s side (i.e., 39 in A3Es and 59 in
A5Es). The alternative sites of A3Es and A5Es are even weaker
than the splice sites ﬂanking alternative cassette exons
(Figure 1; see Tables 1 and 2 for statistical analysis and
Figure S1 for mouse results). Thus, A3Es and A5Es contain a
strong anchor at the constitutive splice site and suboptimal
splice sites at the altered sites.
Next, we tried to understand why the splicing machinery
selects one splice site more frequently than the other, when
the two are located on the same exon. We therefore
determined which is the major and which is the minor splice
site, based on ESTs coverage, requiring at least one transcript
representing each of the forms (see Materials and Methods).
The average number of cDNAs/ESTs per event is 78.27 and
56.12 cDNAs/ESTs for A3E and A5E, respectively. In addition,
the percentage of events that were represented by a small
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Author Summary
Alternative splicing is the mechanism that is responsible for the
creation of multiple mRNA products from a single gene. It is
considered a key player in genomic complexity achievement.
Alternative 39 and 59 splicing events in which part of the exon is
alternatively included or excluded in the mRNA constitute a
significant part of all alternative splicing events, and yet little is
known regarding their regulation mechanism and the evolutionary
background that led to their creation. We show that alternative 39
and 59 splice site exons resemble constitutive exons. However, their
alternative sequence resembles alternative cassette exons. Compa-
rative genomics spanning seven vertebrate species suggests an
evolutionary model in which the alternative state is a derivative of
an ancestral constitutive exon, where a mutation inside the exon or
along the flanking intron resulted in the creation of a new splice site
that competes with the original one, leading to alternative splice site
selection. This model was validated experimentally, showing that
during evolution mutations shifted constitutive exons to undergo
alternative 39 and 59 splicing.
Evolution of Alternative 39 and 59 Spliced Exonsnumber of cDNAs/ESTs is 1% and 2.3% for A3E and A5E,
respectively. It is worth mentioning that we base this method
of major/minor determination on the assumption that the
cDNA/EST coverage of the splice forms properly represents
the cellular situation. We subdivided each of the A3Es and
A5Es into two subgroups, according to their extension
inclusion level: (i) exons whose major splice site is within
the exon—extension inclusion level is less than 40% (group
1); and (ii) exons whose major splice site is at the end of the
exon—extension inclusion level is more than 60% (group 2).
We observed that in A3Es (both group 1 and group 2) and in
group 2 A5Es, the major splice site was signiﬁcantly stronger
than the minor splice site (Wilcoxon, p¼0.01, p¼2.37E-06, p
¼ 0.007 for group 1 A3Es, group 2 A3Es, and group 2 A5Es,
respectively). However, in the case of group 1 A5Es, both
alternative splice sites had a similar splice site score. To
examine this discrepancy further, we examined ESEs’, ESSs’,
and ESRs’ density in the 15 basepairs of the exonic sequences
immediately upstream of the major and minor alternative
59ss (Figure 2A), because it has been found that ESEs, ESSs,
and ESRs in close proximity to the altered site have the major
effect on alternative splicing [9–11]. It is noteworthy that even
though the average distance between the two alternative
splice sites is 63.71 (mean¼22), we cannot absolutely rule out
the possibility that one regulatory element affects both
alternative splice sites. Interestingly, we revealed that in the
case of group 1 A5Es, there is a higher ESE density upstream
of the major splice site than upstream of the minor splice site
(Wilcoxon, p ¼ 0.02 and p ¼ 0.03 for ESRs and ESEs,
respectively; Figure 2B and 2C, right panel). Conversely, in
group 2 A5Es, an opposite trend can be observed, in which
there is a higher ESE density upstream of the minor splice site
than upstream of the major splice site (Wilcoxon, p ¼ 0.001
and p ¼ 0.02 for ESRs and ESEs, respectively). This
phenomenon was demonstrated using both Fairbrother et
al. ESEs and Goren et al. ESRs (Figure 2B and 2C, respectively,
left panel, [10,36]). As opposed to ESEs, we found a lower ESS
density upstream of the major splice site in group 1 exons
and a very high density upstream of the minor splice site
(Wilcoxon, p ¼ 1.80E-04; Figure 2D, right panel; [37]). In
group 2 exons, the results were vice versa, that is, there was a
lower ESS density upstream of the minor splice site and a very
high density upstream of the major splice site (Wilcoxon, p ¼
7.65E-08; Figure 2D, left panel). These results imply that A5Es
require rigorous regulation for the proper selection of
alternative splice sites, which, in the case of group 1 A5Es,
assures the preferential selection of the major splice site
despite the similar score of the two alternative sites. On the
other hand, in the case of group 2 A5Es (in which the major
splice site is stronger than the minor splice site), the
regulatory mechanism is required to support minor splice
site partial selection (see Figure S2 for mouse data). Thus,
Figure 1. Special Characteristics of Alternative 39 and 59 Splicing Sites
Human–mouse conserved 39 and 59 alternative splicing events (A3Es and
A5Es, respectively) were divided into two subgroups according to their
relative usage, in which the alternative splice site that is supported by
most EST/cDNA is called Major, whereas the less-selected site is the
Minor (see Materials and Methods). Splice site score of the 39 and 59
splice sites of constitutive, cassette (exon skipping), alternative 39, and
alternative 59 exons was calculated using the ‘‘Analyzer Splice Tool’’
server (http://ast.bioinfo.tau.ac.il/SpliceSiteFrame.htm). Human exon
scores are shown above the exon/intron junction scheme (see Figure
S1 for mouse scores). Major/Minor splice site is indicated below each
splice site. Exon sequence is represented by a yellow box and the
alternative sequence (extension) by a light blue box. Introns are
represented by black lines; canonical splice sites are shown in bold.
doi:10.1371/journal.pcbi.0030095.g001
Table 2. Statistical Analysis Results for A5Es’ Splice Site
Comparison Analysis
Exons A5Es
Group 1
Major ss
Group 1
Minor ss
Group 2
Major ss
Group 2
Minor ss
Constitutive 4.38E-08 5.22E-07 1.92E-12 1.06E-24
Cassette 1.86E-04 1.00E-03 6.30E-06 2.19E-14
Each cell in the table is the p-value calculated for the given parameter. Results are given for
the alternative 59ss of A5Es.
doi:10.1371/journal.pcbi.0030095.t002
Table 1. Statistical Analysis Results for A3Es’ Splice Site
Comparison Analysis
Exons A3Es
Group 1
Major ss
Group 1
Minor ss
Group 2
Major ss
Group 2
Minor ss
Constitutive 3.86E-05 9.26E-14 1.32E-15 3.05E-38
Cassette 0.72 2.43E-07 2.27E-04 9.05E-15
Each cell in the table is the p-value calculated for the given parameter. Results are given
for the alternative 39ss of A3Es.
doi:10.1371/journal.pcbi.0030095.t001
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Evolution of Alternative 39 and 59 Spliced Exonswhen the two alternative splice sites are of similar strength, a
delicate interplay between ESE and ESS presumably directs
splice site selection between the major and minor sites.
Further, we compared several additional features among
the four datasets. Among the examined features were: exon
length, conservation level between human and mouse (exon
identity), divisibility-by-3 (symmetry), and KA/KS ratio test.
We found that the A3Es (both group 1 and group 2) show
more resemblance to constitutive exons than to alternative
cassette exons (Table 3). For instance, the average length of a
constitutive exon is 132.46 bp (median ¼ 121), which was
found to be very similar to that of A3Es—136.6 (median ¼
128.5) and 147.02 (median ¼ 129.5) for group 1 and group 2
exons, respectively. Statistically, the A3Es show no signiﬁcant
difference from constitutive exons. However, the difference
from alternative cassette exons is signiﬁcant (Mann-Whitney,
p ¼ 4.7E-07 and p ¼ 1.04E-20 for group 1 and group 2 exons,
respectively). Examination of the human–mouse conservation
level showed the same trend. In this case, the A3Es are
signiﬁcantly different from constitutive exons (Mann-Whit-
ney: p ¼ 0.02 and p ¼ 0.04 for group 1 and group 2 exons,
respectively). However, the difference from alternative
cassette exons is much more signiﬁcant (Mann-Whitney, p ¼
2.16E-05 and p ¼ 4.56E-20 for group 1 and group 2 exons,
respectively). The symmetry analysis also showed signiﬁcant
difference from alternative cassette exons (v
2, p ¼ 2.85E-09
Figure 2. ESRs Analysis of Human–Mouse Conserved Alternative 59ss Events
A region 15 bp upstream of the major (59 maj) and minor (59 min) 59ss was screened for ESRs. Average ESR number was calculated for each region. The
analysis was performed for human–mouse conserved 59 alternative splicing events that were divided into two subgroups according to their major/
minor forms and the results were compared with constitutive (Const.) and alternative cassette conserved exons. Left and right panels are ‘‘group 2’’
(major form is longer than minor form) and ‘‘group 1’’ (major form is shorter than minor form) A5Es, respectively.
(A) Schematic illustration of the analysis conducted.
(B) Average ESEs [36].
(C) Average ESRs [10].
(D) Average ESSs [37].
doi:10.1371/journal.pcbi.0030095.g002
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Evolution of Alternative 39 and 59 Spliced Exonsand p¼4.69E-14 for group 1 and group 2 exons, respectively)
and resemblance to constitutive exons (group 1 exons even
presented lower levels of similarity).
The KA/KS ratio test was previously introduced as a tool for
the identiﬁcation of exons within genomic regions [38].
Brieﬂy, the test examines whether the tested exon has evolved
under purifying selection. A prospective research showed
that this tool is more proﬁcient in identifying constitutive
exons rather than alternative cassette exons, which tend to
fail the KA/KS ratio test. Thus, it can serve as a discriminative
tool between constitutive and alternative cassette exons [39].
As anticipated, constitutive and alternative cassette exons
show signiﬁcantly different KA/KS ratio test failure percen-
tages (7.59% and 33.33%, respectively; v
2, p ¼ 8.51E-83).
Regarding A3Es, 12% of group 1 exons and 9.92% of group 2
exons failed the test, showing resemblance to constitutive
exons and a signiﬁcant difference from alternative cassette
exons (v
2, p ¼ 0.41/0.33 and p ¼ 0.03/4.67E-07 for group 1/
group 2 versus constitutive and alternative cassette exons,
respectively).
This same trend of resemblance to constitutive exons can
also be observed in group 1 A5Es (group 1 exons) and in the
length and symmetry features of group 2 A5Es (group 2
exons). However, in the case of group 2 A5Es, the identity
level and KA/KS ratio test features show more signiﬁcant
difference from the constitutive exons than from the
alternative cassette exons (Table 3).
The analysis presented above shows that in the case of A3Es
(both group 1 and group 2) and group 1 A5Es, all features
examined indicate a resemblance to constitutive exons,
whereas group 2 A5Es present inconsistent results (see
Discussion).
We then checked the selected features in the extension
sequence separately (the sequence between the two alter-
native splice sites). We found a high percentage of symmetry
(71.19% and 63.81% for A3Es and A5Es, respectively),
showing resemblance to alternative cassette exons and a
signiﬁcant difference from constitutive exons (v
2, p ¼ 0.114
and p ¼ 1.17E-42 for alternative cassette and constitutive
exons, respectively). This is consistent with the notion that
selective pressure is applied against the formation of an
asymmetrical sequence between two alternative splice sites,
because an asymmetrical sequence would shift the open
reading frame and, hence, could lead to premature trans-
lation termination. Thus, the extension sequences show
characteristics of cassette exons (Table 4).
Conservation Level of Flanking Introns
Intronic sequences ﬂanking constitutive exons show low
conservation levels between human and mouse, whereas
intronic sequences ﬂanking alternatively spliced exons show
88% and 80% conservation of 103 and 94 bp on average for
the upstream and downstream introns, respectively [40]. Also,
tissue-speciﬁc cassette exons are ﬂanked by highly conserved
intronic sequences, even more conserved than cassette exons
[41]. However, intronic sequences ﬂanking the alternative
side of A3Es and A5Es are characterized by a high
conservation level, similar to alternative cassette exons, while
intronic sequences ﬂanking the ﬁxated side are characterized
by a relatively low conservation level, similar to constitutive
exons [6]. A similar observation was also made on the
NAGNAG motif subgroup of A3Es [20]. We thus examined
the conservation of the intronic regions ﬂanking A3Es and
A5Es using a different method for the sequences alignment.
Brieﬂy, we used the local alignment program Sim4 to identify
the human–mouse conserved regions. It is noteworthy that
the intronic region ﬂanking the alternative side was deﬁned
as the sequence downstream of the distal 59ss (‘‘most’’
downstream 59ss) and upstream of the proximal 39ss (‘‘most’’
upstream 39ss) for A5Es and A3Es, respectively (see Materials
and Methods). Figure 3A demonstrates the percentage of
upstream and downstream introns that are conserved
between human and mouse (left and right panels, respec-
tively). As expected, low conservation is observed in the
intronic region ﬂanking the ﬁxated side (median length of 30
bp and 37 bp for A3Es and A5Es, respectively). However,
there is a high conservation level in the intronic region
ﬂanking the alternative side (median length of 42 bp and 57
bp for A3Es and A5Es, respectively). Consequently, this
analysis provides additional evidence for the importance of
Table 4. Features Comparison for Human–Mouse Conserved
Exons (Extension Sequence)
Exon Features Alt 39ss (A3E) Alt 59ss (A5E)
Extension length (median) 27.03 (4) 63.71 (22)
Extension percent identity 95.63 95.50
Extension percent symmetry 71.19 63.81
Extension percent KA/KS ratio test failure 38.33 40.38
Extension length is given in base pairs. Identity, symmetry, and KA/KS values are
represented by percentages.
doi:10.1371/journal.pcbi.0030095.t004
Table 3. Features Comparison for Human–Mouse Conserved Exons (Whole Length Exons)
Exon Features Constitutive (C) Cassette (AS) Alt 39ss (A3E) Alt 59ss (A5E)
Group 1 Group 2 Group 1 Group 2
Exon length (median) 132.46 (121) 97.71 (85.5) 136.60 (128.5) 147.02 (129.5) 162.26 (129) 168.78 (139)
Exon percent identity 87.77 92.17 84.58 87.96 87.26 90.59
Percent symmetry 39.92 66.44 25.00 38.49 46.15 32.98
Percent KA/KS ratio test failure 7.59 33.33 12.00 9.92 11.77 17.95
Bold, values that show a similar trend. Exon length is given in base pairs.
Identity, symmetry, and KA/KS values are represented by percentages.
doi:10.1371/journal.pcbi.0030095.t003
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Evolution of Alternative 39 and 59 Spliced Exonsthe intronic portion located immediately adjacent to the
alternative site, whereas the ﬁxated side is almost free from
that constraint. Presumably, this conserved intronic sequence
is involved in the subtle regulation of alternative splice site
selection.
Another phenomenon that can be observed is that for
A5Es, the conservation level in the alternative side is as high
as in alternative cassette exons. However, A3Es show lower
conservation levels in the alternative side, but higher than
constitutive exons. To further examine this observation, we
decided to divide the A3Es into two subgroups. It has been
previously shown that an additional PPT appears only when
the two alternative 39ss are at least 8 bp apart [24]. Thus, we
used this value as a cutoff for the subdivision. Surprisingly,
repeating the analysis on the two subgroups showed that A3Es
whose alternative splice sites are up to 8 bp apart show a
conservation level similar to constitutive exons (average
conservation length of 44.01 bp and average conservation
level of 82.65), whereas A3Es in which the distance between
the two 39ss is longer than nine nucleotides show a
conservation level that resembles alternative cassette exons
(average conservation length of 69.39 bp and average
conservation level of 86.16; Figure 3B, left panel; Figure
S4A). We conducted the same analysis for A5Es using 6, 8, 9,
and 20 bp as cutoffs, and the most signiﬁcant change in the
behavior of the two subgroups was observed using 8 or 9 bp as
a cutoff (unpublished data). A5Es in which the distance
between the two 59ss is longer than nine nucleotides show a
conservation level that resembles alternative cassette exons
(average conservation length of 71.18 bp and average
conservation level of 84.70), whereas the subgroup of A5Es
whose alternative splice sites are up to 8 bp apart show a
conservation level that is between the constitutive and
alternative cassette exons (Figure 3B, right panel; Figure
S4B). These results imply that there is a difference in the
importance of the intronic regulatory elements according to
the distance between the alternative splice sites: exons that
present a long distance between the two competing splice
Figure 3. Flanking Introns Conservation
Alignment of flanking intron regions was performed using the local alignment program Sim4 for upstream and downstream flanking intron (left and
right panel, respectively). The x-axis represents the identity length (bp) and the y-axis represents the percentage of introns that were found to have an
identity in that length or higher.
(A) Conservation level of flanking introns for constitutive (blue circle), cassette (pink square), alt 39ss (light blue diamond), and alt 59ss (dark red triangle)
exons.
(B) Conservation analysis combined with division of the A3Es and A5Es into two subgroups according to their extension length (8 bp and less versus 9
bp and more). Analysis for the two subgroups is presented for the upstream intron of A3Es (light blue and light green diamonds) and for the
downstream intron of A5Es (dark red and light green triangles).
doi:10.1371/journal.pcbi.0030095.g003
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Evolution of Alternative 39 and 59 Spliced Exonssites rely on intronic sequences for proper alternative splice
site selection, whereas exons that present a short distance
between the two competing splice sites are relatively less
dependent on those intronic sequences. These ﬁndings
provide an additional interpretation to the regulatory
implications of short distance alternative splice sites (see also
[20,22,23]). Tables 5 and 6 summarize the entire statistical
analysis. We also examined the ﬂanking introns conservation
level for group 1 and group 2 exons separately. However, no
signiﬁcant difference was found between these two subgroups
(unpublished data), suggesting that selection of the major/
minor splice site is not regulated via the intronic sequences.
In addition, we observed a ‘‘local peak’’ in the conservation
curve of the ﬂanking introns around 75 bp and 60 bp for
upstream and downstream introns, respectively, suggesting
the preference of regulatory elements in these regions. Such a
peak was previously reported in tissue-speciﬁc alternative
cassette exons [41].
Based on the splice site score analysis, and the ﬂanking
intronic conservation, we suggest that A3Es and A5Es are a
hybrid of constitutive and alternative cassette exons, where
the alternative side of the exon (i.e., 39 in A3Es and 59 in A5Es)
resembles alternative cassette exons, and the ﬁxated side (i.e.,
59 in A3Es and 39 in A5Es) resembles constitutive exons. The
analysis of the characteristic features conducted on the exon
as a whole showing resemblance to constitutive exons with
the extension showing resemblance to alternative cassette
exons further supports this hypothesis.
Alu Elements Flanking Alternative 39 and 59 Exons
Alu elements are primate-speciﬁc retrotransposones, ;300
bp long, that have been shown to play a signiﬁcant role in
gene expression regulation [42]. Alternative cassette exons
are ﬂanked by longer intronic sequences, compared with
constitutively spliced exons [5,43]. Density analysis of Alu
sequences revealed that introns ﬂanking alternative cassette
exons demonstrate a signiﬁcantly higher density of Alu
sequences, compared with constitutive exons [44], which
was also supported by our analysis (3.29/3.03 and 2.12/2 Alu
sequences per intron for upstream/downstream introns of
alternative cassette and constitutive exons, respectively.
Mann-Whitney, p ¼ 0.03/9.39E-05). When the density of Alu
elements was examined in the ﬂanking introns of A3Es, we
found a resemblance to the constitutive exons with 2.44/1.98
Alu sequences for upstream and downstream introns,
respectively (Mann-Whitney, p ¼ 0.40 and p ¼ 0.91 for
upstream and downstream introns, respectively), which
differs signiﬁcantly from alternative cassette exons (Mann-
Whitney, p ¼ 0.048/0.02 for upstream and downstream
introns, respectively). In contrast, A5Es showed an Alu density
that resembles alternative cassette exons. However, these
results were not signiﬁcant.
Evolution of A3Es and A5Es
We conducted a human–mouse KA/KS ratio analysis of the
exonic region that is present in both the spliced variants (the
short form, or core) of each exon, versus the extension
sequence. The analysis was performed for group 1 and group
2 exons separately. Based on the KA/KS ratio results, which
indicated that the extension sequence behaves differently for
group 1 and group 2 exons (Figures 4 and 5, panels (i)), we set
to examine the evolutionary constraints affecting A3Es and
A5Es. Altogether, we randomly selected and examined 13
cases for which we found the homologue exon and ﬂanking
Table 5. Statistical Analysis of A3Es’ Flanking Introns Conservation
Introns A3E
Upstream Intron Downstream Intron
8 bp and Less 9 bp and More
Identity Length Percent Conservation Identity Length Percent Conservation Identity Length Percent Conservation
Constitutive 0.04 0.001 9.96E-24 1.12E-21 7.15E-19 0.005
Cassette 7.49E-14 3.55E-06 0.554 0.36 0.01 0.035
Each cell in the table is the p-value calculated for the given parameter.
doi:10.1371/journal.pcbi.0030095.t005
Table 6. Statistical Analysis of A5Es’ Flanking Introns Conservation
Introns A5E
Upstream Intron Downstream Intron
8 bp and Less 9 bp and More
Identity Length Percent Conservation Identity Length Percent Conservation Identity Length Percent Conservation
Constitutive 0.005 0.09 0.06 2.69E-04 4.22E-28 1.00E-11
Cassette 1.54E-08 2.57E-07 0.09 0.14 0.13 0.055
Each cell in the table is the p-value calculated for the given parameter.
doi:10.1371/journal.pcbi.0030095.t006
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Evolution of Alternative 39 and 59 Spliced Exonsexons sequences in the HomoloGene database among seven
organisms (see below). Three of these cases showed putative
functional alternative splice sites among all seven organisms,
but no support was found for the alternative state for some of
the organisms, probably because of a low EST/cDNA coverage
of this region. In the remaining ten cases we found a
functional alternative splice site only in some of the species.
Figures 4 and 5 show four of such cases: one example
representing a group 1 exon and one example representing a
group 2 exon for both A3Es and A5Es. For each of the
selected exons and ﬂanking splice sites, we used the
HomoloGene database to extract orthologous genes in seven
different organisms [45]: human (Homo sapiens), mouse (Mus
musculus), rat (Rattus), opossum (Didelphis virginiana), chicken
(Gallus gallus), xenopus (Xenopus tropicalis), and zebraﬁsh (Danio
rerio); and generated a multiple sequence alignment among
these seven species using ClustalW [46]. In group 1 A3E
(human PRPF3 gene), we found the KA/KS ratio of the major
(short) form to be 0.001 (KA¼0.0002, KS¼0.1677) and the KA/
KS ratio of the extension to be 99 (KA ¼ 0.0476, KS ¼ 0.0005.
Such a high ratio indicates that synonymous substitutions
practically do not occur; Figure 4A, panel (i)). The multiple
alignment of this exon revealed that the major (short) form is
relatively conserved among the seven species (63.16%), while
the extension showed poor conservation (13.33%). In
addition, we found that at the minor splice site, a functional
AG dinucleotide exists only among the mammals, whereas in
chicken, xenopus, and zebraﬁsh a nonfunctional 39ss is
Figure 4. Mutations That Introduced a New Competing 39ss Shifted Splicing from Constitutive to Alternative During Evolution
Multiple alignment of homolog exons and flanking intronic sequences among seven vertebrate species was constructed according to a known
evolutionary tree (see Table S1A for the sequences accessions) using ClustalW ([46]; http://www.ebi.ac.uk/clustalw).
(A,B) The analysis was conducted on ‘‘group 1’’ and ‘‘group 2’’ alternative 39ss exons, respectively. In the top panel (i) is a schematic representation of
the handled exon. Exon sequence is represented by a yellow box and the alternative sequence (extension) by a light blue box. Introns are represented
by black lines. The human–mouse KA/KS values and identity percentage are shown above the boxes. Major and minor splice site is indicated below the
boxes as well. The organisms that have a potential (according to their splice site content) to have either both alternatively spliced forms or only one of
the forms are shown on the left of the schema. In the middle panel (ii) is a multiple alignment, among the seven species, of the exon and flanking 39 and
59 splice sites. The major 39ss (M), minor 39ss (m), and 59ss are marked in red and pointed to by an arrow. Intronic regions are highlighted in light grey.
On the bottom panel (iii) is an RT–PCR analysis on normal brain cDNA of human, mouse, and rat (H, M, and R, respectively), chicken 5-d embryo (C),
adult zebrafish whole body (Z), and xenopus oocytes (X). PCR products were amplified using species-specific primers, and splicing products were
separated on a 3% agarose gel and sequenced. Asterisks point to the alternative isoform; an illustration of both alternative isoforms is shown on the
right by grey, cyan, and white boxes (alternative exon, extension, and flanking exons, respectively).
doi:10.1371/journal.pcbi.0030095.g004
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Evolution of Alternative 39 and 59 Spliced Exonspresent: either AA or GG dinucleotides in that site (Figure
4A, panel (ii)). We also observed that in human, mouse, rat,
and chicken, a relatively strong PPT exists at the minor splice
site, while in xenopus and zebraﬁsh, no such sequence is
present. Based on a known evolutionary tree, the most
plausible scenario is that a mutation from A to G occurred,
which created a functional AG 39ss in human, mouse, rat, and
opossum and resulted in the emergence of a new A3E. We
noticed that no evidence (EST or cDNA) for alternative
splicing was found for rat or opossum. However, this is likely
a consequence of relatively small amounts of deposited
mRNA and EST sequences that cover that locus.
Next, we validated these results experimentally in six of the
seven species (human, mouse, rat, chicken, xenopus, and
zebraﬁsh). We designed primers for the ﬂanking exons in
each of these organisms. Total RNA was extracted from brain
tissues of human, mouse, and rat, from a whole organism of
chicken and zebraﬁsh, and from xenopus’ oocytes. This was
followed by RT–PCR (reverse transcription–polymerase chain
reaction) analysis and sequencing of all PCR products. The
pairs of primers used in the RT–PCR were designed
speciﬁcally to amplify a similar size of PCR product for the
extension–inclusion isoform among the different organisms
of the same ortholog. The experimental results validated that
the alternative form was unique to human, mouse, and rat,
which, as indicated above, have a functional minor splice site
(Figure 4A, panel (iii); lanes H, M, R, which are abbreviations
for human, mouse, and rat, respectively). In chicken, xenopus,
and zebraﬁsh, which were shown not to have an additional
functional splice site, the exon is constitutively spliced
Figure 5. Mutations That Introduced a New Competing 59ss Shifted Splicing from Constitutive to Alternative during Evolution
Multiple alignment of homolog exons and flanking intronic sequences among seven vertebrate species was constructed according to a known
evolutionary tree (see Table S1B for the sequences accessions) using ClustalW ([46]; http://www.ebi.ac.uk/clustalw).
(A,B) The analysis was conducted on ‘‘group 1’’ and ‘‘group 2’’ alternative 59ss exons, respectively. In the top panel (i) is a schematic representation of
the handled exon. Exon sequence is represented by a yellow box and the alternative sequence (extension) by a light blue box. Introns are represented
by black lines. The human–mouse KA/KS values and identity percentage are shown above the boxes. Major and minor splice site is indicated below the
boxes as well. The organisms that have a potential (according to their splice site content) to have either both alternatively spliced forms or only one of
the forms are shown on the left of the schema. In the middle (ii) panel is a multiple alignment, among the seven species, of the exon and flanking 39 and
59 splice sites. The major 59ss (M), minor 59ss (m), and 39ss are marked in red and pointed to by an arrow. Intronic regions are highlighted in light grey.
On the bottom panel (iii) is an RT–PCR analysis on normal brain cDNA of human, mouse, and rat (H, M, and R, respectively), chicken 5-d embryo (C),
adult zebrafish whole body (Z), and xenopus oocytes (X). PCR products were amplified using species-specific primers, and splicing products were
separated on a 3.5% agarose gel and sequenced. Asterisks point to the alternative isoform; an illustration of both alternative isoforms is shown on the
right by grey, cyan, and white boxes (alternative exon, extension, and flanking exons, respectively).
doi:10.1371/journal.pcbi.0030095.g005
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Evolution of Alternative 39 and 59 Spliced Exons(Figure 4A, panel (iii); panels C, Z, X, which are abbreviations
for chicken, xenopus, and zebraﬁsh, respectively). We note,
that whenever the alternative 39ss or 59ss isoforms were not
detected, longer exposure of the gels did not indicate its
presence. However, this did not rule out completely that this
alternative isoform (or selection of another cryptic splice site)
might be detected under different conditions. Based on the
phylogenetic relationships among the analyzed organisms
and these results, we conclude that the alternative splice
variant is a derived form, and the constitutive spliced variant
is the ancestral one. Moreover, the constitutive form observed
for chicken, xenopus, and zebraﬁsh is also the major mRNA
product of the human, mouse, and rat alternative forms. This
indicates that the major form, which is the ancestral
conserved isoform, is also the major mRNA product after
the transition from constitutive to alternative splice site
selection. Presumably, this is needed to prevent selection
against the alternative isoform.
Unlike the group 1 A3E, in the group 2 A3E (human
UBQLN4 gene), the KA/KS ratio of the extension is similar to
that of the minor (short) form (Figure 4B, panel (i)). The
multiple alignment shows that the exon is conserved among
the seven species throughout its full length (62.5%) and that
only human, mouse, and rat present a functional minor splice
site (AG), whereas opossum, chicken, and zebraﬁsh contain
TG in the reciprocal positions, and xenopus contains CG in
the reciprocal positions. The minor splice site is within the
exon, which is relatively conserved among the seven species.
Thus, we ﬁnd a relatively strong PPT at the minor splice site
in all seven species. The minor 39ss was presumably created
during evolution following a mutation in the ﬁrst position of
the AG 39ss (Figure 4B, panel (ii)). The experimental results
verify that only the human, mouse, and rat present two
alternatively spliced forms, which is compatible with the
bioinformatic analysis, while the chicken and zebraﬁsh (no
PCR product was observed for xenopus) present only one
constitutive splice form (Figure 4B, panel (iii)). The different
size of the chicken PCR product is due to the fact that the
forward primer was designed on the A3E, because the
upstream exon does not exist in the University of California
Santa Cruz Genome (UCSC) Browser (see Table S1). Again,
the major mRNA product is the major form, which is the
constitutive and only mRNA product in chicken and zebra-
ﬁsh, suggesting that it is the ancestral form. Based on the
phylogenetic relationships among the analyzed organisms, we
concluded that the alternative splice variant is a derived
form, and the constitutive spliced variant is the ancestral one.
A corresponding trend can be observed in group 1 A5E
(human ACTR6 gene; Figure 5A) and group 2 A5E (human
NCOR1 gene; Figure 5B). The chicken PCR product is
different in size, because the forward primer was designed
on the A5E, as the upstream sequence is not fully mapped in
the UCSC Genome Browser (see Table S1).
The tested exons are alternatively spliced in human, mouse,
and rat. In these species, the ancestral form is also the major
mRNA product, but these exons are constitutively spliced in
chicken, xenopus, and zebraﬁsh (Figures 4 and 5, panel (iii)).
Based on the phylogenetic relationships among the analyzed
organisms and the above results, we concluded that the
examined cases of A3Es and A5Es originated from a
constitutive ancestral form (originally including the alter-
native extension or excluding it). Mutations upstream or
downstream of the ancestral splice site created a new
functional splice site that competes with the original splice
site, but with a lower selection level. This competition results
in an alternative selection between those sites. This hypoth-
esis is consistent with the high level of similarity found
between A3Es and A5Es and constitutive exons. It is worth
mentioning that although we only demonstrated four cases,
in which the origin of alternative 39ss and 59ss is from
previously constitutively spliced exons, we believe that since
these cases are representatives of the four exon groups, and
their characteristics apply to all exons, we thus suspect that a
major portion of the A3Es and A5Es originated by this
process.
Discussion
Here we used bioinformatic tools to examine A3Es and
A5Es that are conserved between human and mouse and,
thus, are potentially functionally meaningful events. We
divided each of the A3Es and A5Es datasets into two
subgroups: one in which the major splice form is spliced
using the splice site within the exon (group 1) and the other
in which the major splice form is spliced using the splice site
at the end of the exon (group 2), according to each of their
alternative forms inclusion level. We used these four
subgroups to examine unique characteristics that distinguish
these types of splicing events. It has been previously shown
that constitutive and alternative cassette exons differ in
several features, such as exon length, conservation level
between human and mouse (exon identity), divisibility-by-3
(symmetry), and KA/KS ratio test [6,14,29,39]. We demonstra-
ted that A3Es and A5Es, as a whole, show a resemblance in the
aforementioned characterizing features to constitutive exons
and differ from alternative cassette exons. These ﬁndings are
statistically signiﬁcant for group 1 and group 2 A3Es, as well
as for group 1 A5E exons.
Further, we showed that when examining splice site
strength, ﬂanking introns conservation, and Alu density in
the ﬁxated side (i.e., 59 in A3Es and 39 in A5Es) and the
alternative side (i.e., 39 in A3Es and 59 in A5Es) separately, we
ﬁnd that the ﬁxated side shows a resemblance to constitutive
exons, whereas the alternative side shows a resemblance to
alternative cassette exons. Thus, we suggest that A3Es and
A5Es can be regarded as an intermediate state between
constitutive and alternative cassette exons. Moreover, we
showed that the alternative side of the A5Es requires precise
regulation, presumably to achieve proper splice site selection.
Previously, it was shown that ESE and ESS elements have the
major effect on splicing when located in proximity to the
alternative splice site [9–11]. In the case of group 1 A5Es, this
regulation is essential, because both alternative splice sites
are of similar strength; high ESE/ESR and low ESS density in
proximity to the major splice site are probably the major
factors that govern the level of each site usage in splicing. On
the other hand, in group 2 A5Es, the major splice site is
stronger than the minor splice site. Thus, the ESE/ESR density
is higher, and the ESS density is lower in proximity to the
minor splice site. This provides relative predominance and
enables the selection level of the minor splice site and, thus,
presumably regulates alternative splice site selection. It is
noteworthy that examination of the ESR density in proximity
to the alternative splice sites in A3Es found no signiﬁcant
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A3Es belong to the NAGNAG family [20,21,24], and, thus, the
alternative forms differ from each other by only 3 bp, which
makes the region scanned for ESRs overlap between the two
alternative forms. Also, it is possible that, in A3Es, the ESRs
play a minor role in the decision of major/minor 39ss
selection and that screening downstream of the branch site
determines alternative 39ss usage [47,48].
Relying on the assumption that sequence conservation
implies functional properties, we conducted an analysis on
the conservation of ﬂanking intronic sequences. In agree-
ment with other reports [6,20], we showed that the con-
servation level of the intronic sequence ﬂanking the
alternative side resembles the conservation level observed
in alternative cassette exons. This analysis also revealed that,
while the conservation level in the downstream intron
ﬂanking A5Es is relatively similar to alternative cassette
exons, the conservation level of the upstream intron ﬂanking
A3Es is in between the conservation level of constitutive and
alternative cassette exons. To resolve this discrepancy, we
decided to divide the A3Es dataset into two subgroups that
are secluded by the length of the extension sequence. The
chosen cutoff was 8 bp, which is based on a previous report
showing that an additional PPT appears only when the two
alternative splice sites are at least 8 bp apart [24]. We were
intrigued to ﬁnd that the subgroup whose extension is 8 bp or
less presents a low intronic conservation level that resembles
constitutive exons, while the subgroup whose extension is 9
bp or larger presents a high intronic conservation level which
resembles alternative cassette exons. This suggests that
regulation via the intronic sequences on alternative 39ss
occurs only when the alternative splice sites are not in close
proximity, whereas selection of splice sites that are located in
close proximity may be ‘‘noise’’ of the splicing mechanism
[23]. We conducted the same analysis on A5Es and found that
the subgroup of exons whose extension is 8 bp or less shows a
conservation level that is between constitutive and alternative
cassette exons, and the other subgroup showed a high
conservation level that is similar to (and even higher than)
alternative cassette exons (Figure 3 and Tables 5 and 6).
The KA/KS ratio is used for the estimation of the selective
forces acting on proteins [14]. That is, KA/KS   1 indicates
purifying selection and KA/KS   1 indicates positive
selection. We used this estimation tool to examine whether
the selective forces throughout evolution acted in a different
way on the core exon (i.e., the exon sequence not including
the region that is alternatively spliced) compared with the
alternative region (i.e., the region which is either included or
not). We performed the analysis for the subgroup of exons for
which the major splice site is within the exon (group 1) and
for the subgroup of exons for which the major splice site is at
the end of the exon (group 2) separately. In both group 1 and
group 2 exons, the core exon presented KA/KS   1, indicating
high purifying selection. In group 1 exons, the extension (i.e.,
the alternative region) generally presented KA/KS   1,
indicating that it is under positive selection, so that the
extension form is free to evolve and eventually potentially
acquire a new function. In contrast, in the case of group 2
exons, the alternative region generally presented KA/KS   1,
which was relatively similar to the core KA/KS, indicating that
the same selective forces have acted on both regions. This
raises the possibility that, in the case of group 1 exons, the
extension region was newly introduced during evolution,
while in the case of group 2 exons the extension region was
part of the original exon.
Based on this analysis, we suggest that dynamic evolution is
the key for the emergence of a new A3E or A5E. We propose
that a certain fraction of the A3Es and A5Es originated from
a previously constitutively spliced exon that acquired a
competing splice site upstream or downstream of the
ancestral authentic splice site. As a result, both sites are
selected, thus giving birth to an alternative 59ss or 39ss exon.
We believe that selective forces acted to ensure the symmetry
of the created alternative region (the region between the
authentic splice site and newly created splice site), to
maintain the same reading frame as that of the ancestral
form, presumably by the selection of events that ensure this
symmetry. We also assume that, initially, the selection of the
new splice site was very rare and lacked biological function-
ality, but during the course of evolution such functionality
was acquired, in a process that is called exaptation [49]. Thus,
an ancestral form including the extension (i.e., alternative
splice site is within the original ancestral exon sequence) will
show a similar KA/KS ratio throughout the exon, because the
same evolutionary purifying selection forces took effect
before and after the appearance of the alternative splice site.
However, an ancestral form excluding the extension (alter-
native splice site is inside the ﬂanking intron) will show a
higher KA/KS ratio in the extension (alternative added
sequence) than in the original short form, because the
evolutionary purifying selection forces began operating at a
much later time. We have shown that in four tested features,
the A3Es and A5Es are similar to constitutive exons (see
above). However, in one subset of group 2 A5Es, the exons are
more similar in their conservation level and in their KA/KS
ratio to alternative cassette exons than to constitutive exons.
We believe that the evolutionary model described previously
can also serve as a possible explanation for these results. That
is, the alternative 59ss appeared during evolution within
exons that were already under purifying selection to maintain
the coding sequence. Thus, the exon that includes the
alternative region is the evolutionary ancient one, and the
exon that excludes the alternative region is the new addition.
Another possibility is that A3Es and A5Es can also originate
from alternative cassette exons in which one of the splice sites
(59ss in A3Es and 39ss in A5Es) is strengthened, because of
mutations, and an existing or a newly generated cryptic splice
site began to be selected as an alternative splice site.
We decided to examine our hypothesis of constitutive
origin on a limited number of exons manually; one example
represented a group 1 exon and one example represented a
group 2 exon for both A3Es and A5Es. We used multiple
species alignment of seven species for each of the selected
exons and their ﬂanking splice sites to pinpoint the molecular
evolutionary changes. The multiple alignments show that
while in chicken, xenopus, and zebraﬁsh only one functional
splice site can be observed (AG and GT for 39ss and 59ss,
respectively), in human, mouse, rat, and, sometimes, in
opossum, another alternative functional splice site was
created by a mutation during evolution. It suggests that,
based on a known evolutionary tree (see Figure S3), the
appearance of new functional alternative splice sites as a
result of mutations in the discussed examples is mammal-
speciﬁc (not necessarily in all mammals). We further validated
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scenario is that A3Es and A5Es were originated from
previously constitutive exons. In these exons, an alternative
splice site emerged in the lineage leading to mammals,
following a mutation that created a functional 39ss or 59ss (AG
or GT, respectively). After the creation of the alternative site,
selection pressures show differences between sites created
outside of the ancestral exon or within the ancestral exon. In
the case of group 1 exons relative to the ancestral form, the
extension is poorly conserved (between the seven species) and
presents KA/KS   1, while in the group 2 exons, the extension
is relatively highly conserved and presents KA/KS , 1.
Although our analysis experimentally validates the hypothesis
for these cases, a broader evolutionary examination and
large-scale analysis is still required to examine the scope and
magnitude of this phenomenon.
In conclusion, we examined the characteristics of A3Es’ and
A5Es’ splicing forms, showing that A3Es and A5Es contain an
anchor splice site that is as strong as that of constitutive
exons and alternative sites that are weaker than cassette
exons. We propose an evolutionary dynamic model in which
A3Es and A5Es originated from ancestral constitutive exons
that following mutation/s, a new alternative splice site
appeared, and started competing with the ancient one for
splice site selection. This model is supported by bioinformatic
analysis showing that A3Es and A5Es are similar to
constitutive exons. It was validated for four exons by multiple
species’ comparison and experimental validation. We also
present that when two alternative 59ss are of a similar
strength, a delicate ratio between ESE/ESS located immedi-
ately upstream of each splice site determines which one is the
major or minor selected site. In addition, A3Es and A5Es
whose alternative splice sites are at least 9 bp apart show a
high intronic sequences conservation level, indicative of the
participation in the splicing regulation of these exons.
Materials and Methods
Dataset compilation. We assembled a uniﬁed dataset of human–
mouse orthologous exons [6,30,31]. The dataset included 45,553
constitutively spliced exons, 757 cassette exons, 530 A3Es, and 232
A5Es. For each of the A3Es and A5Es, obtained from Sugnet et al.
(2004), we extracted the DNA and mRNA sequences using the BLAST
program and produced an exon/intron structure using the Sim4
program. The Sim4 program receives a DNA sequence and an mRNA
sequence and projects the mRNA onto the DNA considering the
exon/intron architecture and the ﬂanking consensus splice sites. This
led to acquisition of both forms of A3Es and A5Es, including their
respective ﬂanking intronic sequences. For the Carmel et al. (2004)
and Sorek et al. (2004) datasets, this information was already
extracted.
Establishing major/minor form subgroup division. The dataset of
A3Es and A5Es was divided into two subgroups: (i) exons whose major
splice site is within the exon and (ii) exons whose major splice site is
at the end of the exon. These subgroups were deﬁned as ‘‘group 1’’
and ‘‘group 2,’’ respectively (Figure 1). The determination of whether
an exon is in one subgroup or another was made by locating all the
mRNA and EST sequences hits received from blasting that exon and
the ﬂanking exons against all the sequences in the UCSC database
(http://genome.ucsc.edu), requiring at least one transcript represent-
ing each form. The number of long forms, i.e., those that include the
alternative region (NL), versus short forms, i.e., those that exclude the
alternative region (NS), were counted, and the extension inclusion
percentage (i.e., the fraction of mRNAs and ESTs containing the
alternative region) was calculated as [NL /( N L þ NS)] * 100. Exons
whose extension inclusion percentage was less than 40% were
attributed to ‘‘group 1,’’ and exons whose extension inclusion
percentage was more than 60% were attributed to ‘‘group 2.’’ Exons
whose extension inclusion percentage was in the range of 40% to
60% were not included in either group, so as to prevent false
predictions resulting from a low EST coverage or borderline cases.
Splice site score analysis. 39ss and 59ss scores were extracted using a
program based on the ‘‘Analyzer Splice Tool’’ server (http://ast.
bioinfo.tau.ac.il/SpliceSiteFrame.htm). The program was adjusted for
multisequence analysis, using the algorithm of Shapiro and Sena-
pathy (1987). Only canonical splice sites (i.e., AG in positions  2 and
 1 for 39ss and GT in positions þ1 and þ2 or GCA in positions þ1t o
þ3 for 59ss) were considered. The analysis was executed for the human
and mouse splice sites separately.
Calculation of ﬂanking introns identity percentile. A region of 100
bp for each ﬂanking intron was selected. The intronic region ﬂanking
the alternative side was deﬁned as the sequence downstream of the
distal 59ss (‘‘most’’ downstream 59ss) and upstream of the proximal
39ss (‘‘most’’ upstream 39ss) for A5Es and A3Es, respectively. A
homology examination was performed using Sim4 [50] with its
default parameters. Brieﬂy, this program detects exact matches of
length 12 and extends them in both directions with a score of 1 for a
match and  5 for a mismatch, stopping when extensions no longer
increase the score. For homology of 100 bp long, the following 100 bp
were also examined (and so on). The length of the homology was
deﬁned as the sum of lengths of the homology regions identiﬁed by
Sim4 (L1..n), and the weighted identity percentage was calculated as
(Ri¼1..n Li *I i)/Ri¼1..n Li, where Ii is the identity percentage for the I’th
homology region. The relative percentile was calculated for each of
the sequences. The A3Es and A5Es datasets were then both divided
into two subgroups, according to the length of the extension (number
of bp between the alternative splice sites) when the cutoff used was 8
bp. The analysis was then also conducted for each subgroup
separately.
Multispecies alignment of alternatively spliced exon and ﬂanking
splice sites. The exon and ﬂanking splice site sequences of rat,
opossum, chicken, xenopus, and zebraﬁsh were extracted, using the
UCSC Genome Browser (http://genome.ucsc.edu). The sequences of
the seven species (including human and mouse) were aligned using
the ClustalW program, with its default parameters ([46], http://www.
ebi.ac.uk/clustalw). Major and minor (authentic—i.e., supported by
mRNAs or ESTs; potential—i.e., not supported by mRNAs and ESTs
and noncanonical) 39ss and 59ss were located and marked.
Total RNA isolation and RT–PCR ampliﬁcation. Chicken (5-d
embryo) and zebraﬁsh (adult) were disrupted in TRIzol (Sigma, http://
www.sigmaaldrich.com) with a Polytron homogenizer (PT-MR2100
Kinematica, http://www.kinematica.ch), or with a hand-held motor-
pestle (Kimble-Kontes, http://www.kimble-kontes.com) for the xen-
opus’ oocytes. After complete homogenization of the tissue, the total
RNA was isolated. The samples were treated with 2U of RNase-free
DNase (Ambion, http://www.ambion.com). RT was performed on 1–2
lg total RNA using RT–AMV (avian myeloblastosis virus, Roche,
http://www.roche.com) following the manufacturer’s protocol. We
used commercial brain cDNA for human, mouse, and rat (BioChain,
http://www.biochain.com). Endogenous PCR ampliﬁcation was per-
formed, using Taq polymerase (BioTools, http://www.btools.com) and
species-speciﬁc primers (see Table S2 for the sequences of the
primers). Ampliﬁcation was performed for 30 cycles, consisting of
denaturation for 30 s at 94 8C, annealing for 45 s at the appropriate
Tm, and elongation for 1–2 min at 72 8C. The spliced cDNA products
were separated in 3%–3.5% agarose gel. We note that, in the case of
UBQLN4 (Figure 4B (iii)) and NCOR1 (Figure 5B (iii)) exons, the RT–
PCR failed to amplify the cDNA of the xenopus. All PCR products
were eluted and sequenced.
Supporting Information
Figure S1. Special Characteristics of Alternative 39 and 59 Splicing
Sites
Human–mouse conserved 39 and 59 alternative splicing events (A3Es
and A5Es, respectively) were divided into two subgroups according to
their major/minor selected sites (see Materials and Methods). Splice
site score analysis of the 39 and 59 splice sites of constitutive, cassette
(exon skipping), alternative 39, and alternative 59 exons was
conducted. Human and mouse exon scores are shown above the
exon/intron junction scheme (mouse scores are below the human
scores). Major/Minor splice site is indicated below each splice site.
Exon sequence is represented by a yellow box and the alternative
sequence (extension) by a light blue box. Introns are represented by
black lines, canonical splice sites are shown in bold.
Found at doi:10.1371/journal.pcbi.0030095.sg001 (264 KB PDF).
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Evolution of Alternative 39 and 59 Spliced ExonsFigure S2. ESRs Analysis of Human–Mouse Conserved Alternative
59ss Events
A region 15 bp upstream of the major (59 maj) and minor (59 min) 59ss
was screened for ESRs. Average ESR number was calculated for each
region. The analysis was done for human–mouse conserved 59
alternative splicing events that were divided into two subgroups
according to their major/minor forms (see Materials and Methods)
and compared to constitutive (Const.) and alternative cassette
conserved exons. Left and right panels are ‘‘group 2’’ (major form
is longer than minor form) and ‘‘group 1’’ (major form is shorter than
minor form) A5Es, respectively. Human and mouse results are in light
blue and purple, respectively.
(A) Schematic illustration of the analysis conducted.
(B) Average ESEs [36].
(C) Average ESRs [10].
(D) Average ESSs [37].
Found at doi:10.1371/journal.pcbi.0030095.sg002 (323 KB PDF).
Figure S3. Evolutionary Tree of the Seven Analyzed Species
A phylogenetic evolutionary tree spanning the seven analyzed species
built based on previous evolutionary studies [51].
Found at doi:10.1371/journal.pcbi.0030095.sg003 (102 KB PDF).
Figure S4. Flanking Introns Average Conservation Length
Alignment of ﬂanking intron regions was performed using the local
alignment program Sim4 for upstream and downstream ﬂanking
intron (A and B, respectively). The x-axis represents the group of
exons and the y-axis represents the average conservation length (bp).
Found at doi:10.1371/journal.pcbi.0030095.sg004 (180 KB PDF).
Table S1. Accession Numbers of the Seven Analyzed Vertebrate
Species
Found at doi:10.1371/journal.pcbi.0030095.st001 (39 KB DOC).
Table S2. Primers Used in the Experimental Validation
Found at doi:10.1371/journal.pcbi.0030095.st002 (58 KB DOC).
Accession Numbers
Accession numbers from the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/RefSeq) are: Homo sapiens
PRPF3 (NM_004698), Gallus gallus (NM_001031390), Homo sapiens
UBQLN4 (NM_020131), Mus musculus (NM_033526), Gallus gallus
(NM_001031373), Xenopus tropicalis (NM_001037720), Danio rerio
(NM_213356), Homo sapiens ACTR6 (NM_022496), Xenopus tropicalis
(NM_001016472), and Homo sapiens NCOR1 (NM_006311).
Accession numbers from The National Center for Biotechnology
Information GenBank (http://www.ncbi.nlm.nih.gov/Genbank) are
Mus musculus (BC026607), Rattus (CB586372), Xenopus tropicalis
(CX437471), Danio rerio (CK028262), Rattus (CB747083), Mus musculus
(CK617284), Rattus (CK365697), Danio rerio (BC045961), Rattus
(CB546074), Gallus gallus (BU326580), Xenopus tropicalis (BC099620),
and Danio rerio (CK015548).
The accession number from the EMBL Nucleotide Sequence
Database (http://www.ebi.ac.uk/embl) is Gallus gallus (AJ719762).
The accession number from the DNA Data Bank of Japan (http://
www.ddbj.nig.ac.jp) is Mus musculus (AB093281).
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